![]() |
市場調查報告書
商品編碼
1288666
全球可吸收抗菌包膜市場研究報告 - 行業分析、規模、佔有率、成長、趨勢和2023年至2030年預測Global Absorbable Antibacterial Envelope Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030 |
到2030年,全球對可吸收抗菌包膜的需求將從2022年的35.94百萬美元達到近71.82百萬美元的市場規模,在2023-2030年的研究期間,年復合成長率為9.04%。
可吸收的抗菌封套是一種醫療設備,可以減少接受心臟植入手術的病人的感染風險,如心臟起搏器或除顫器的植入。該設備由一種生物可吸收的聚合物基質製成,其中含有抗生素,如米諾環素和利福平,在植入後的幾週內逐漸釋放。可吸收抗菌包膜在手術時放置在植入式設備周圍,旨在在設備與周圍組織之間提供物理屏障。包膜內的抗生素會隨著時間的推移緩慢釋放,有助於防止植入物部位的感染。該設備通常用於發生感染的高風險患者,例如以前在心臟植入部位感染過的患者或患有使他們更容易感染的潛在疾病的患者。可吸收抗菌包膜是心臟植入領域的重要進步,因為植入部位的感染可能很嚴重,可能危及生命。使用該封套可以幫助減少這些感染的發生率,從而改善病人的治療效果,降低醫療費用。
心血管疾病的發病率越來越高,加上人口老齡化,正在推動對心臟植入手術的需求。這推動了對可吸收抗菌包膜的需求,這種包膜用於防止植入部位的感染。心臟植入部位的感染可能是嚴重的,並威脅到生命。事實證明,使用可吸收抗菌包膜可以減少這些感染的發生率,從而促使對這些設備的需求增加。開發更先進、更有效的可吸收抗菌包膜在預防感染方面更有效,而且比早期版本的副作用更少。可吸收抗菌包膜的好處,如減少感染風險和縮短住院時間,在病人和醫療機構中越來越為人所知。這正在推動對這些設備的需求。世界各國政府都在鼓勵採用抗菌醫療設備,包括可吸收抗菌封套,以減少感染的發生率和改善病人的治療效果。
該研究報告涵蓋了波特的五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清楚地瞭解行業結構,並在全球範圍內評估競爭吸引力。此外,這些工具還對全球可吸收抗菌包膜市場的每個細分市場進行了包容性評估。可吸收抗菌信膜行業的發展和趨勢為本研究提供了整體方法。
本節涵蓋了區域前景,強調了北美、歐洲、亞太、拉丁美洲以及中東和非洲地區對可吸收抗菌包膜市場的當前和未來需求。此外,該報告重點關注所有突出地區的各個應用部門的需求、估計和預測。
該研究報告還涵蓋了市場中主要參與者的全面概況和對全球競爭格局的深入看法。可吸收抗菌包膜市場的主要參與者包括Medtronic plc和Aziyo Biologics, Inc。這一部分包括對競爭格局的整體看法,其中包括各種戰略發展,如主要的合併和收購,未來的能力,夥伴關係,財務概況,合作,新產品的開發,新產品的推出,以及其他發展。
注意- 在公司簡介中,財務細節和最近的發展情況取決於可用性,可能不包括私人公司在內。
The global demand for Absorbable Antibacterial Envelope Market is presumed to reach the market size of nearly USD 71.82 MN by 2030 from USD 35.94 MN in 2022 with a CAGR of 9.04% under the study period 2023-2030.
An absorbable antibacterial envelope is a medical device that reduces the risk of infections in patients undergoing cardiac implant procedures, such as pacemakers or defibrillator implantation. The device is made of a bio-absorbable polymer matrix that contains antibiotics, such as minocycline and rifampin, which are released gradually over a period of several weeks after implantation. The Absorbable Antibacterial Envelope is placed around the implantable device at the time of the procedure and is designed to provide a physical barrier between the device and surrounding tissue. The antibiotics within the envelope are released slowly over time, helping to prevent infection at the site of the implant. The device is typically used in patients who are at a high risk of developing infections, such as those who have previously had infections at the site of a cardiac implant or those who have underlying medical conditions that make them more susceptible to infections. The Absorbable Antibacterial Envelope is an important advancement in the field of cardiac implantation, as infections at the site of the implant can be serious and potentially life-threatening. The use of the envelope can help to reduce the incidence of these infections, leading to better patient outcomes and reduced healthcare costs.
The growing incidence of cardiovascular disease, coupled with an aging population, is driving the demand for cardiac implant procedures. This is driving the demand for absorbable antibacterial envelopes, which are used to prevent infections at the site of the implant. Infections at the site of cardiac implants can be serious and life-threatening. The use of absorbable antibacterial envelopes has been shown to reduce the incidence of these infections, leading to increased demand for these devices. Development of more advanced and effective absorbable antibacterial envelopes are more effective at preventing infections and have fewer side effects than earlier versions. The benefits of absorbable antibacterial envelopes, such as the reduced risk of infection and shorter hospital stays, are becoming increasingly well-known among patients and healthcare providers. This is driving the demand for these devices. Governments around the world are encouraging the adoption of antibacterial medical devices, including absorbable antibacterial envelopes, to reduce the incidence of infections and improve patient outcomes.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of absorbable antibacterial envelope. The growth and trends of absorbable antibacterial envelope industry provide a holistic approach to this study.
This section of the absorbable antibacterial envelope market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
This section covers the regional outlook, which accentuates current and future demand for the Absorbable Antibacterial Envelope market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the absorbable antibacterial envelope market include Medtronic plc and Aziyo Biologics, Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies